article Open AccessTop 1% cited
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
BMJ · 2020 · Vol. 369 · pp. m1849–m1849
Wei Tang✉(Shanghai Jiao Tong University)Zhujun Cao(Shanghai Jiao Tong University)Mingfeng Han(Fuyang City People's Hospital)Zhengyan Wang(Hubei University of Medicine)Junwen Chen(Hubei University of Medicine)Wenjin Sun(Ezhou Central Hospital)Yaojie WuWei Xiao(First People's Hospital of Jingzhou)Shengyong Liu(The Central Hospital of Xiao gan)Erzhen Chen(Shanghai Jiao Tong University)Wei Chen(Shanghai Jiao Tong University)Xiongbiao Wang(Shanghai University of Traditional Chinese Medicine)Jiuyong Yang(The Central Hospital of Xiao gan)Jun Lin(Wuhan University)Qingxia Zhao(The Sixth People's Hospital of Zhengzhou)Youqin Yan(Wuhan No. 7 Hospital)Zhibin Xie(The Central Hospital of Xiao gan)Dan Li(Second Hospital of Yichang)Yaofeng Yang(Xiaogan First People's Hospital)Leshan Liu(Shanghai Jiao Tong University)Jieming Qu(Shanghai Jiao Tong University)Guang Ning(Shanghai Jiao Tong University)Guochao Shi(Shanghai Jiao Tong University)Qing Xie(Shanghai Jiao Tong University)
Abstract
ChiCTR2000029868.
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19HydroxychloroquineMedicineAdverse effectInternal medicinePopulationCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)
MeSH terms
COVID-19COVID-19 Drug TreatmentAdultAntiviral AgentsChinaFemaleHumansHydroxychloroquineMaleMiddle AgedPneumonia, ViralTreatment OutcomeCoronavirus InfectionsPandemics
Funding
- Shanghai Key Discipline for Respiratory Diseases
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- Ruijin Hospital
- School of Medicine, Shanghai Jiao Tong University
- National Key Research and Development Program of China
Citations
1,054
FWCI
26.12
field-weighted impact
References
19
Percentile
99%
vs. same field & year
Citations per year
Cited by
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
JAMA · 2020 · 4,760 citations
References
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Clinical Infectious Diseases · 2020 · 2,765 citations
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
JAMA · 2020 · 5,332 citations
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
BMJ · 2020 · 4,150 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.